Role of Intestinal Microbiota in Ulcerative Colitis
Role of Intestinal Microbiota in Ulcerative Colitis
Role of Intestinal Microbiota in Ulcerative Colitis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
32. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. (2004) Use <strong>of</strong> 16S rRNA gene‐targeted group‐specific<br />
primers for real‐time PCR analysis <strong>of</strong> predom<strong>in</strong>ant bacteria <strong>in</strong> human feces. Applied and Environmental<br />
Microbiology. 70:7220‐7228.<br />
33. Matsuki T, Watanabe K, Tanaka R, Oyaizu H. (1998) Rapid identification <strong>of</strong> human <strong>in</strong>test<strong>in</strong>al bifidobacteria by<br />
16S rRNA‐targeted species‐ and group‐specific primers. Fems Microbiology Letters. 167:113‐121.<br />
34. O'Sullivan DJ, Kullen MJ. (1998) Track<strong>in</strong>g <strong>of</strong> probiotic bifidobacteria <strong>in</strong> the <strong>in</strong>test<strong>in</strong>e. International Dairy<br />
Journal. 8:513‐525.<br />
35. Ott SJ, Musfeldt M, Timmis KN, Hampe J, Wenderoth DF, Schreiber S. (2004) In vitro alterations <strong>of</strong> <strong>in</strong>test<strong>in</strong>al<br />
bacterial microbiota <strong>in</strong> fecal samples dur<strong>in</strong>g storage. Diagnostic Microbiology and Infectious Disease. 50:237‐<br />
245.<br />
36. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J et al.. (2007) A comparative study <strong>of</strong> the<br />
preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus<br />
acidophilus, <strong>in</strong> the TNBS model <strong>of</strong> rat colitis. Journal <strong>of</strong> Applied Microbiology. 103:836‐844.<br />
37. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL et al.. (2006) Lactobacillus fermentum, a<br />
probiotic capable to release glutathione, prevents colonic <strong>in</strong>flammation <strong>in</strong> the TNBS model <strong>of</strong> rat colitis.<br />
International Journal <strong>of</strong> Colorectal Disease. 21:737‐746.<br />
38. Pfaffl MW: Relative Quantification. In Real‐Time PCR. Edited by Torak D. Taylor & Francis; 2006:63‐82.<br />
39. Png CW, L<strong>in</strong>den SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI et al.. (2010) Mucolytic Bacteria With<br />
Increased Prevalence <strong>in</strong> IBD Mucosa Augment In Vitro Utilization <strong>of</strong> Muc<strong>in</strong> by Other Bacteria. American Journal<br />
<strong>of</strong> Gastroenterology. 105:2420‐2428.<br />
40. Pullan RD, Thomas GAO, Rhodes M, Newcombe RG, Williams GT, Allen A et al.. (1994) Thickness <strong>of</strong> Adherent<br />
Mucus Gel on Colonic Mucosa <strong>in</strong> Humans and Its Relevance to <strong>Colitis</strong>. Gut. 35:353‐359.<br />
41. Q<strong>in</strong> JJ, Li RQ, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al.. (2010) A human gut microbial gene<br />
catalogue established by metagenomic sequenc<strong>in</strong>g. Nature. 464:59‐70.<br />
42. Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S. (2006) Anti‐<strong>in</strong>flammatory effects <strong>of</strong><br />
bifidobacteria by <strong>in</strong>hibition <strong>of</strong> LPS‐<strong>in</strong>duced NF‐kappa B activation. World Journal <strong>of</strong> Gastroenterology. 12:3729‐<br />
3735.<br />
43. Sartor RB. (2008) Therapeutic correction <strong>of</strong> bacterial dysbiosis discovered by molecular techniques.<br />
Proceed<strong>in</strong>gs <strong>of</strong> the National Academy <strong>of</strong> Sciences <strong>of</strong> the United States <strong>of</strong> America. 105:16413‐16414.<br />
44. Sartor RB. (2006) Mechanisms <strong>of</strong> disease: pathogenesis <strong>of</strong> Crohn's disease and ulcerative colitis. Nature Cl<strong>in</strong>ical<br />
Practice Gastroenterology & Hepatology. 3:390‐407.<br />
45. Sartor RB. (2004) Therapeutic manipulation <strong>of</strong> the enteric micr<strong>of</strong>lora <strong>in</strong> <strong>in</strong>flammatory bowel diseases:<br />
Antibiotics, probiotics, and prebiotics. Gastroenterology. 126:1620‐1633.<br />
46. Sega<strong>in</strong> JP, de la Bletiere DR, Bourreille A, Leray V, Gervois N, Rosales C et al.. (2000) Butyrate <strong>in</strong>hibits<br />
<strong>in</strong>flammatory responses through NF kappa B <strong>in</strong>hibition: implications for Crohn's disease. Gut. 47:397‐403.<br />
47. Shanks OC, Atikovic E, Blackwood AD, Lu JR, Noble RT, Dom<strong>in</strong>go JS et al.. (2008) Quantitative PCR for<br />
detection and enumeration <strong>of</strong> genetic markers <strong>of</strong> bov<strong>in</strong>e fecal pollution. Applied and Environmental<br />
Microbiology. 74:745‐752.<br />
24